159
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Gender-Specific Impact of Metabolic Obesity Phenotypes on the Risk of Hashimoto's Thyroiditis: A Retrospective Data Analysis Using a Health Check-Up Database

ORCID Icon, , , , &
Pages 827-837 | Published online: 07 Feb 2022

References

  • Tsigalou C, Vallianou N, Dalamaga M. Autoantibody production in obesity: is there evidence for a link between obesity and autoimmunity? Curr Obes Rep. 2020;9(3):245–254. doi:10.1007/s13679-020-00397-8
  • Bluher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298. doi:10.1038/s41574-019-0176-8
  • Baranowska-Bik A, Bik W. The association of obesity with autoimmune thyroiditis and thyroid function-possible mechanisms of bilateral interaction. Int J Endocrinol. 2020;2020:8894792. doi:10.1155/2020/8894792
  • Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4–5):391–397. doi:10.1016/j.autrev.2014.01.007
  • Versini M, Jeandel PY, Rosenthal E, et al. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981–1000. doi:10.1016/j.autrev.2014.07.001
  • Song RH, Wang B, Yao QM, et al. The impact of obesity on thyroid autoimmunity and dysfunction: a systematic review and meta-analysis. Front Immunol. 2019;10:2349. doi:10.3389/fimmu.2019.02349
  • Santini F, Marzullo P, Rotondi M, et al. Mechanisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. Eur J Endocrinol. 2014;171(4):R137–R152. doi:10.1530/EJE-14-0067
  • McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252–265. doi:10.1007/s12020-012-9703-2
  • Macdougall CE, Wood EG, Loschko J, et al. Visceral adipose tissue immune homeostasis is regulated by the crosstalk between adipocytes and dendritic cell subsets. Cell Metab. 2018;27(3):588–601. doi:10.1016/j.cmet.2018.02.007
  • Mraz M, Haluzik M. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol. 2014;222(3):R113–R127. doi:10.1530/JOE-14-0283
  • Chang Y, Kim BK, Yun KE, et al. Metabolically-healthy obesity and coronary artery calcification. J Am Coll Cardiol. 2014;63(24):2679–2686. doi:10.1016/j.jacc.2014.03.042
  • Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med. 2008;168(15):1617–1624. doi:10.1001/archinte.168.15.1617
  • Wang T, Lu J, Shi L, et al. Association of insulin resistance and beta-cell dysfunction with incident diabetes among adults in China: a nationwide, population-based, prospective cohort study. Lancet Diabetes Endocrinol. 2020;8(2):115–124. doi:10.1016/S2213-8587(19)30425-5
  • Chang Y, Ryu S, Cho J, et al. Metabolically healthy obesity and development of chronic kidney disease. Ann Intern Med. 2016;165(10):744–745. doi:10.7326/L16-0405
  • National Clinical Research Center of Geriatric. [Expert consensus of the diagnosis and treatment measures for the Chinese elderly patients with type 2 diabetes (2018 Edition)]. Zhonghua Nei Ke Za Zhi. 2018;57(9):626–641. Chinese. doi:10.3760/cma.j.issn.0578-1426.2018.09.004.
  • Alberti KG, Zimmet P, Shaw J. The metabolic syndrome–a new worldwide definition. Lancet. 2005;366(9491):1059–1062. doi:10.1016/S0140-6736(05)67402-8
  • Wang Y, Lin H, Li Q, et al. Association between different obesity phenotypes and hypothyroidism: a study based on a longitudinal health management cohort. Endocrine. 2021;72(3):688–698. doi:10.1007/s12020-021-02677-2
  • Francisco V, Ruiz-Fernandez C, Pino J, et al. Adipokines: linking metabolic syndrome, the immune system, and arthritic diseases. Biochem Pharmacol. 2019;165:196–206. doi:10.1016/j.bcp.2019.03.030
  • Vieira-Potter VJ. Inflammation and macrophage modulation in adipose tissues. Cell Microbiol. 2014;16(10):1484–1492. doi:10.1111/cmi.12336
  • Yang H, Youm YH, Vandanmagsar B, et al. Obesity increases the production of proinflammatory mediators from adipose tissue T cells and compromises TCR repertoire diversity: implications for systemic inflammation and insulin resistance. J Immunol. 2010;185(3):1836–1845. doi:10.4049/jimmunol.1000021
  • Wang SH, Chen GH, Fan Y, et al. Tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis by the expansion of CD4+CD25+ regulatory T cells. Endocrinology. 2009;150(4):2000–2007. doi:10.1210/en.2008-1389
  • Sakaguchi S, Ono M, Setoguchi R, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212(1):8–27. doi:10.1111/j.0105-2896.2006.00427.x
  • Fortunato RS, Ferreira AC, Hecht F, et al. Sexual dimorphism and thyroid dysfunction: a matter of oxidative stress? J Endocrinol. 2014;221(2):R31–R40. doi:10.1530/JOE-13-0588
  • Sosic-Jurjevic B, Filipovic B, Renko K, et al. Testosterone and estradiol treatments differently affect pituitary-thyroid axis and liver deiodinase 1 activity in orchidectomized middle-aged rats. Exp Gerontol. 2015;72:85–98. doi:10.1016/j.exger.2015.09.010
  • Ong KK, Kuh D, Pierce M, et al. Childhood weight gain and thyroid autoimmunity at age 60–64 years: the 1946 British birth cohort study. J Clin Endocrinol Metab. 2013;98(4):1435–1442. doi:10.1210/jc.2012-3761
  • Amouzegar A, Kazemian E, Abdi H, et al. Abdominal obesity phenotypes and incidence of thyroid autoimmunity: a 9-year follow-up. Endocr Res. 2020;45(3):202–209. doi:10.1080/07435800.2020.1749847
  • Pan B, Zhang Q, Zhou H, et al. Prevalence of components of metabolic syndrome among adults with the presence of autoimmune thyroid condition in an iodine-sufficient region. Biol Trace Elem Res. 2021;199(8):2837–2843. doi:10.1007/s12011-020-02413-3
  • Mousa U, Bozkus Y, Kut A, et al. Fat distribution and metabolic profile in subjects with Hashimoto’s thyroiditis. Acta Endocrinol. 2018;14(1):105–112. doi:10.4183/aeb.2018.105
  • Ren R, Ma Y, Deng F, et al. Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study. Diabetes Metab Syndr Obes. 2019;12:1563–1569. doi:10.2147/DMSO.S202769
  • Tamer G, Mert M, Tamer I, et al. Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia. Endokrynol Pol. 2011;62(5):421–428.
  • Kim HJ, Park SJ, Park HK, et al. Thyroid autoimmunity and metabolic syndrome: a nationwide population-based study. Eur J Endocrinol. 2021;185(5):707–715. doi:10.1530/EJE-21-0634
  • Wu Y, Shi X, Tang X, et al. The correlation between metabolic disorders and TPOAb/TgAb: a cross-sectional population-based study. Endocr Pract. 2020;26(8):869–882. doi:10.4158/EP-2020-0008
  • Waliszewska-Prosol M, Bladowska J, Budrewicz S, et al. The evaluation of Hashimoto’s thyroiditis with event-related potentials and magnetic resonance spectroscopy and its relation to cognitive function. Sci Rep. 2021;11(1):2480. doi:10.1038/s41598-021-82281-6
  • Bladowska J, Waliszewska-Prosol M, Ejma M, et al. The metabolic alterations within the normal appearing brain in patients with Hashimoto’s thyroiditis are correlated with hormonal changes. Metab Brain Dis. 2019;34(1):53–60. doi:10.1007/s11011-018-0318-z